SCHEMBL2419110

SCHEMBL2419110

CC(C)CC(C)C1CCCCC1

nearest known ligand 0.46

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
SHBG P04278 1/20 0.44
EPHX1 P07099 2/20 0.39
TP53 P04637 1/20 0.36
MMP1 P03956 2/20 0.35
MMP9 P14780 2/20 0.35
MMP14 P50281 2/20 0.35
KDM4E B2RXH2 1/20 0.34
GMNN O75496 1/20 0.34
LMNA P02545 1/20 0.34
MAPT P10636 1/20 0.34
BLM P54132 1/20 0.34
PMP22 Q01453 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
MMP2 P08253 1/20 0.34
MMP3 P08254 1/20 0.34
IDO1 P14902 1/20 0.33
TDO2 P48775 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8076025 1.00 SHBG (0.44) SHBGEPHX1TP53MMP1MMP9
SCHEMBL4653053 0.97 SHBG (0.40) SHBGEPHX1TP53MMP1MMP9
SCHEMBL748900 0.89 SHBG (0.48) SHBGEPHX1TP53KDM4EGMNN
SCHEMBL4654274 0.86
SCHEMBL6014415 0.80 EPHX1 (0.41) SHBGEPHX1TP53KDM4EGMNN
SCHEMBL20049927 0.80 SHBG (0.41) SHBGEPHX1TP53KDM4EGMNN
SCHEMBL20600325 0.80 SHBG (0.41) SHBGEPHX1TP53KDM4EGMNN
SCHEMBL26986871 0.80 TP53 (0.43) SHBGEPHX1TP53KDM4EGMNN
SCHEMBL18898352 0.80 SHBG (0.41) SHBGEPHX1TP53KDM4EGMNN
SCHEMBL8939611 0.78 SHBG (0.50) SHBGEPHX1TP53KDM4EGMNN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117143476-A Hydrocarbon solvent 日铁化学材料株式会社 2023-12-01 CN disclosed
EP-2722323-B1 Process for the preparation of 2-methyl-4-phenyl-2-pentanol BASF SE (DE) 2018-11-28 EP disclosed
EP-2755938-B1 METHOD FOR PRODUCING 4-CYCLOHEXYL-2-METHYL-2-BUTANOL BASF SE (DE) 2017-03-01 EP disclosed
CN-106187685-A The method preparing 4 cyclohexyl 2 methyl 2 butanol 巴斯夫欧洲公司 2016-12-07 CN disclosed
US-20160311741-A1 PROCESS FOR PREPARING 4-CYCLOHEXYL-2-METHYL-2-BUTANOL BASF SE (DE) 2016-10-27 US disclosed
CN-105967975-A Process for the preparation of 4-cyclohexyl-2-methyl-2-butanol 巴斯夫欧洲公司 2016-09-28 CN disclosed
CN-103796980-B Process for preparing 4-cyclohexyl-2-methyl-2-butanol 巴斯夫欧洲公司 2016-08-31 CN disclosed
US-9416079-B2 Process for preparing 4-cyclohexyl-2-methyl-2-butanol BASF SE (DE) 2016-08-16 US disclosed
CN-102822130-B Process for preparing 4-cyclohexyl-2-methyl-2-butanol 巴斯夫欧洲公司 2016-06-08 CN disclosed
US-20150246864-A1 PROCESS FOR PREPARING 4-CYCLOHEXYL-2-METHYL-2-BUTANOL BASF SE (DE) 2015-09-03 US disclosed
US-8450534-B2 Process for preparing 4-cyclohexyl-2-methyl-2-butanol BASF SE (DE) 2013-05-28 US disclosed
WO-2013037737-A1 METHOD FOR PRODUCING 4-CYCLOHEXYL-2-METHYL-2-BUTANOL BASF SE (DE) 2013-03-21 WO disclosed
US-20130072726-A1 PROCESS FOR PREPARING 4-CYCLOHEXYL-2-METHYL-2-BUTANOL BASF SE (DE) 2013-03-21 US disclosed
EP-2550248-A2 PROCESS FOR THE PREPARATION OF 4-CYCLOHEXYL-2-METHYL-2-BUTANOL BASF SE (DE) 2013-01-30 EP disclosed
CN-102822130-A Process for preparing 4-cyclohexyl-2-methyl-2-butanol BASF SE 2012-12-12 CN disclosed
WO-2011117360-A2 PROCESS FOR THE PREPARATION OF 4-CYCLOHEXYL-2-METHYL-2-BUTANOL BASF SE (DE) 2011-09-29 WO disclosed
US-20110237684-A1 Process for preparing 4-cyclohexyl-2-methyl-2-butanol BASF SE (DE) 2011-09-29 US disclosed
EP-1986598-A1 UV FILTER CAPSULES COMPRISING AN AMINOSUBSTITUTED HYDROXYBENZOPHENONE Merck Patent GmbH (DE) 2008-11-05 EP disclosed
WO-2007093252-A1 UV FILTER CAPSULES COMPRISING AN AMINOSUBSTITUTED HYDROXYBENZOPHENONE MERCK PATENT GMBH (DE) 2007-08-23 WO disclosed
US-4345004-A Process for forming a coated film of an olefinic resin HERCULES INCORPORATED (US) 1982-08-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110237684-A1 Process for preparing 4-cyclohexyl-2-methyl-2-butanol CYP4B1, HPD, ADH1C SHBG 4537/4885EPHX1 2471/4885TP53 2402/4885
US-20160311741-A1 PROCESS FOR PREPARING 4-CYCLOHEXYL-2-METHYL-2-BUTANOL ADH1C, CYP4B1, ADH1A SHBG 4338/4885EPHX1 2602/4885TP53 2253/4885
US-20130072726-A1 PROCESS FOR PREPARING 4-CYCLOHEXYL-2-METHYL-2-BUTANOL ADH1C, CYP4B1, ADH1A SHBG 4338/4885EPHX1 2602/4885TP53 2253/4885
US-20150246864-A1 PROCESS FOR PREPARING 4-CYCLOHEXYL-2-METHYL-2-BUTANOL ADH1C, CYP4B1, ADH1A SHBG 4338/4885EPHX1 2602/4885TP53 2253/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.